Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2025-12-25 @ 4:28 AM
NCT ID:
NCT06449820
Eligibility Criteria:
Inclusion Criteria:
* Patient ≥ 18 years old,
* Established diagnosis of ulcerative colitis as per ECCO (European Crohn´s and Colitis Organisation) criteria,
* Hospitalisation at any point for treatment of ulcerative colitis disease relapse,
* Receiving at least one dose of tofacitinib, filgotinib, or upadacitinib for the treatment of severe UC during inpatient stay,
* Endoscopically confirmed active disease (Mayo endoscopic subscore ≥ 2) within previous four weeks,
* Patient who has received full information about the organization of the research and who has not objected to his or her participation and to the use of his or her data.
Exclusion Criteria:
* Diagnosis of Crohn's disease or unclassified Inflammatory Bowel Disease,
* Receiving JAKi prior to admission,
* Clostridium difficile, cytomegalovirus (CMV), or other enteric infections identified on admission.
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06449820
Study Brief:
Protocol Section:
NCT06449820